Literature DB >> 1607518

Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction.

P Perrone-Filardi1, S L Bacharach, V Dilsizian, S Maurea, J A Marin-Neto, J A Arrighi, J A Frank, R O Bonow.   

Abstract

Reduced end-diastolic wall thickness with absent systolic wall thickening has been reported to represent nonviable myocardium in patients with chronic coronary artery disease. To assess whether reduced regional end-diastolic wall thickness and absent wall thickening accurately identify nonviable myocardium, 25 patients with ischemic left ventricular dysfunction (ejection fraction at rest 27 +/- 10%) underwent positron emission tomography with oxygen-15-labeled water and 18fluorodeoxyglucose to assess metabolic activity and spin-echo gated nuclear magnetic resonance imaging to measure regional end-diastolic wall thickness and wall thickening. The presence of metabolic activity was defined as 18fluorodeoxyglucose uptake (corrected for partial volume) greater than 50% of that in normal regions. Of 355 myocardial regions evaluated, 266 were hypokinetic or normokinetic at rest and 89 were akinetic (that is, absent wall thickening). 18Fluorodeoxyglucose uptake was observed in 97% of the hypokinetic and normokinetic regions and in 74% of the akinetic regions. End-diastolic wall thickness was greater in akinetic regions with than in those without 18fluorodeoxyglucose uptake (11 +/- 4 vs. 7 +/- 3 mm, p less than 0.01). The highest values for sensitivity and specificity of end-diastolic wall thickness in predicting the absence of metabolic activity in akinetic regions were 74% and 79%, respectively, and corresponded to an end-diastolic threshold of 8 mm. However, the positive predictive accuracy was only 55% and did not improve for other end-diastolic wall thickness values. In all myocardial regions, there was only a weak correlation between 18fluorodeoxyglucose activity and either end-diastolic wall thickness (r = 0.17) or wall thickening (r = 0.32). Thus, metabolic activity is present in many regions with reduced end-diastolic wall thickness and absent wall thickening. These data indicate that assessment of regional anatomy and function may be inaccurate in distinguishing asynergic but viable myocardium from nonviable myocardium.

Entities:  

Mesh:

Year:  1992        PMID: 1607518     DOI: 10.1016/0735-1097(92)90153-e

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

1.  Reinjection of thallium for detection of viable myocardium: why not do it immediately?

Authors:  B L van Eck-Smit; E E van der Wall
Journal:  Br Heart J       Date:  1995-08

2.  Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging: a powerful predictor of outcome.

Authors:  G A Beller; M Ragosta
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

Review 3.  Radionuclide techniques for the assessment of myocardial viability.

Authors:  E Skoufis; A I McGhie
Journal:  Tex Heart Inst J       Date:  1998

Review 4.  Myocardial Viability on Cardiac Magnetic Resonance.

Authors:  Ana Luiza Mansur Souto; Rafael Mansur Souto; Isabella Cristina Resende Teixeira; Marcelo Souto Nacif
Journal:  Arq Bras Cardiol       Date:  2017-05       Impact factor: 2.000

5.  Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: a cardiac magnetic resonance imaging study.

Authors:  Tienush Rassaf; Johannes Nolte; Nicole Heussen; Gaby A Krombach; Rolf W Günther; Malte Kelm; Harald P Kühl
Journal:  Clin Res Cardiol       Date:  2010-02-12       Impact factor: 5.460

6.  Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease.

Authors:  W Hayashida; C van Eyll; M F Rousseau; H Pouleur
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  Defect reversibility using thallium-201 reinjection. Comparison of stress-redistribution-reinjection with stress-immediate reinjection.

Authors:  B L van Eck-Smit; A F Kuijper; A H Zwinderman; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Int J Card Imaging       Date:  1996-03

Review 8.  Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques.

Authors:  U Sechtem; E Voth; F Baer; C Schneider; P Theissen; H Schicha
Journal:  Int J Card Imaging       Date:  1993

9.  Role of myocardial perfusion single photon emission computed tomography in pediatric cardiology practice.

Authors:  P Shanmuga Sundaram; S Padma
Journal:  Ann Pediatr Cardiol       Date:  2009-07

Review 10.  Assessment of left ventricular dysfunction by nuclear cardiology.

Authors:  J A Melin; W Wijns; J L Vanoverschelde; G R Heyndrickx
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.